NEWS: $198.5M Partnership with Canada & Alberta Govts to Biomanufacture Next-Gen Meds

Entos Pharmaceuticals
Home
Technology
Pipeline & Partners
Team
News & Media
Careers & Culture
Contact
Entos Pharmaceuticals
Home
Technology
Pipeline & Partners
Team
News & Media
Careers & Culture
Contact
More
  • Home
  • Technology
  • Pipeline & Partners
  • Team
  • News & Media
  • Careers & Culture
  • Contact
  • Home
  • Technology
  • Pipeline & Partners
  • Team
  • News & Media
  • Careers & Culture
  • Contact

Jason Ding, FCPA, FCA, CBV, ICD.D

CHIEF BUSINESS OFFICER

Jason Ding has almost 20 years of financial and transactional expertise in the life science and healthcare industry. He has served as a Partner and Senior Managing Director in Deloitte’s investment banking practice and as a National Life Sciences & Healthcare Transactions Leader spearheading transactions with a cumulative value of over $1.5 billion in the last two years. Jason worked with start-ups, large public companies, and global consulting companies and has been an investor and a Board member for numerous life science and industry organizations. Mr. Ding is a Fellow of the Chartered Professional Accountants of Alberta (FCPA, FCA), a Chartered Business Valuator (CBV), received ICD.D designation with the Institute of Corporate Directors, and a BSc. and BCom. from the University of Alberta.

Copyright © 2025 Entos Pharmaceuticals - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept